Amedeo Smart

Free Medical Literature Service

 

Amedeo

Bladder Cancer
  Free Subscription

Articles published in
Urol Int
    March 2024
  1. DUAN H, Deng Z, Zou J, Zhang G, et al
    The efficacy and safety of Hyperthermia intravesical chemotherapy in the treatment non-muscle invasive bladder cancer:A meta analysis.
    Urol Int. 2024 Mar 20. doi: 10.1159/000538373.
    >> Share

    January 2024
  2. REIKE MJ, Reicherz A, Tully KH, Bahlburg H, et al
    An empirical survey on the adaption of neoadjuvant chemotherapy in bladder cancer.
    Urol Int. 2024 Jan 19. doi: 10.1159/000536321.
    >> Share

  3. BANEK S, Hoeh B, Cano Garcia C, Koll F, et al
    Metastatic Squamous Cell Carcinoma of the Urinary Bladder: Urgent Call for New Therapies.
    Urol Int. 2024;108:1-8.
    >> Share

  4. VOLZ Y, Trappmann R, Ebner B, Eismann L, et al
    Upstaging after Transurethral Resection of the Bladder for Non-Muscle-Invasive Cancer of the Bladder: Who Is at Highest Risk?
    Urol Int. 2024;108:42-48.
    >> Share

  5. GARAZ R, Stuhler V, Stenzl A, Rottscholl R, et al
    Hemangioma of the Urinary Bladder: A Brief Narrative Review of Their Diagnosis, Histology, and Treatment Options.
    Urol Int. 2024;108:83-88.
    >> Share

  6. WALACH MT, Nitschke K, Gross-Weege M, Grosshans J, et al
    Cyclin A2 Expression as Predictive Biomarker in Muscle-Invasive Upper Tract Urothelial Carcinoma.
    Urol Int. 2024;108:128-136.
    >> Share

    December 2023
  7. GUO Y, Li C, Zhang S, Zhu G, et al
    U-Net-Based Assistive Identification of Bladder Cancer: A Promising Approach for Improved Diagnosisc.
    Urol Int. 2023 Dec 11. doi: 10.1159/000535652.
    >> Share

    November 2023
  8. GUO L, Zhang T, Taisheng L, Chen J, et al
    Laparoscopic Radical Cystectomy With Ileal Orthotopic Neobladder for Bladder Cancer: Current Indications and Outcomes.
    Urol Int. 2023 Nov 23. doi: 10.1159/000535032.
    >> Share

    September 2023
  9. CHEN Z
    The Role of Specificity Protein 1 (SP1) in Bladder Cancer Progression through PTEN-Mediated AKT/mTOR Pathway.
    Urol Int. 2023 Sep 4:1-9. doi: 10.1159/000532128.
    >> Share

    August 2023
  10. JIAO H, Wang L, Zhou X, Wu J, et al
    Prognostic Ability of Nutritional Indices for Outcomes of Bladder Cancer: A Systematic Review and Meta-Analysis.
    Urol Int. 2023 Aug 29:1-9. doi: 10.1159/000531884.
    >> Share

    June 2023
  11. DU J, Zhan H, Chen J, Wang J, et al
    The Influence of Preoperative Hydronephrosis on the Prognosis after Radical Cystectomy among Patients with Different Pathological Stages of Bladder Cancer.
    Urol Int. 2023 Jun 2:1-8. doi: 10.1159/000531080.
    >> Share

    March 2023
  12. FU Y, Liu K, Jiang X, Zhao L, et al
    Hsa_circ_0008035 Knockdown Inhibits Bladder Cancer Progression through miR-1184/RAP2B Axis.
    Urol Int. 2023 Mar 23:1-14. doi: 10.1159/000527873.
    >> Share

    February 2023
  13. BOLAT D, Baltaci S, Akgul M, Karabay E, et al
    Predictive Role of the Systemic Immune Inflammation Index for Intravesical BCG Response in Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer.
    Urol Int. 2023 Feb 21:1-7. doi: 10.1159/000528740.
    >> Share

    January 2023
  14. FITOUSSI O, Roche JB, Riviere J, Wallerand H, et al
    Accuracy of FDG-PET/CT for Response Evaluation of Muscle-Invasive Bladder Cancer following Neoadjuvant or Induction Chemotherapy.
    Urol Int. 2023 Jan 19:1-7. doi: 10.1159/000528524.
    >> Share

  15. TACHIBANA T, Ikeda M, Shimura S, Amano N, et al
    Efficacy of Intravesical Instillation Therapy with Low-Dose Tokyo-172 Bacillus Calmette-Guerin to Prevent Recurrence of Non-Muscle-Invasive Bladder Cancer and Treat Carcinoma in situ: A Multi-Institutional Retrospective Study.
    Urol Int. 2023 Jan 16:1-9. doi: 10.1159/000527718.
    >> Share

  16. KORKES F, Timoteo F, Baccaglini W, Glina F, et al
    Postoperative Mortality Rate after Radical Cystectomy: A Systematic Review of Epidemiologic Series.
    Urol Int. 2023;107:96-104.
    >> Share

  17. ZANG Z, Kesavan NR, Esuvaranathan K
    UBC(R)Rapid Is Sensitive in Detecting High-Grade Bladder Urothelial Carcinoma and Carcinoma in situ in Asian Population.
    Urol Int. 2023;107:29-34.
    >> Share

  18. SCHNEIDEWIND L, Drager DL, Rossberg V, Nolting J, et al
    Prospective Evaluation of Health-Related Quality of Life in Patients with Metastatic Urothelial Carcinoma Undergoing Immunotherapy with Pembrolizumab: Symptom Burden Can Predict Survival.
    Urol Int. 2023;107:80-86.
    >> Share

  19. MICHAEL KGFT, Ravindranath N, Michael S, German A, et al
    Optimizing Upper-Tract Imaging for Non-Visible Haematuria.
    Urol Int. 2023;107:23-28.
    >> Share

  20. ZHANG Y, Ding H, Zhang Y, Tian J, et al
    Is Anti-Reflux Anastomosis an Advantage in an Orthotopic Ileal Neobladder? A Systematic Review and Meta-Analysis.
    Urol Int. 2023;107:1-14.
    >> Share

  21. EISMANN L, Bohn L, Buchner A, Casuscelli J, et al
    Age and ECOG Performance Status as Predictors of Survival of Patients with Upper Urinary Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy.
    Urol Int. 2023;107:72-79.
    >> Share

  22. HAAS M, Knobloch C, Mayr R, Gierth M, et al
    Short-Term and Long-Term Morbidity after Radical Cystectomy in Patients with NMIBC and Comparison with MIBC: Identifying Risk Factors for Severe Short-Term Complications.
    Urol Int. 2023;107:246-256.
    >> Share

  23. MEYER HJ, Wienke A, Zamsheva M, Surov A, et al
    Low Skeletal Muscle Mass Predicts Relevant Outcomes in Palliative Urological Oncology: A Systematic Review and Meta-Analysis.
    Urol Int. 2023;107:219-229.
    >> Share

  24. CHEN S, Gao Y, Chen F, Wang TB, et al
    ANLN Serves as an Oncogene in Bladder Urothelial Carcinoma via Activating JNK Signaling Pathway.
    Urol Int. 2023;107:310-320.
    >> Share

  25. HAEUSER L, Marchese M, Noldus J, Kibel AS, et al
    Association between Operative Time and Short-Term Radical Cystectomy Complications.
    Urol Int. 2023;107:273-279.
    >> Share

  26. GRUNE B, Menold H, Lenhart M, Muhlbauer J, et al
    Patient Compliance in Assessing Electronic Patient-Reported Outcome Measures after Urologic Surgery.
    Urol Int. 2023;107:280-287.
    >> Share

  27. BOLENZ C, Kunath F, Zengerling F, Wezel F, et al
    Increasing Biomarker Guidance in the Treatment of Urothelial Carcinoma: Systematic Review of International Clinical Trials.
    Urol Int. 2023;107:480-488.
    >> Share

  28. GRUNE B, Kowalewski KF, Weiss C, Neuberger M, et al
    Predicting Complexity in Transurethral Resection of Bladder Tumours: External Validation and Modification of the Bladder Complexity Score.
    Urol Int. 2023;107:583-590.
    >> Share

  29. WU YL, Li ZQ, Wu AM
    The Misdiagnosis of Intravesical Ectopic Prostatic Tissue as a Tumor.
    Urol Int. 2023;107:738-741.
    >> Share

  30. STRUCK JP, Ozimek T, Schnoor M, Offermann A, et al
    The Role of Urine and Washing Cytology in Primary Transurethral Resection of Bladder Tumours.
    Urol Int. 2023;107:792-800.
    >> Share

  31. BOKARICA P, Alfirevic M, Hrkac A, Glas AM, et al
    Letter to the Editor regarding the Article "Postoperative Mortality Rate after Radical Cystectomy: A Systematic Review of Epidemiologic Series".
    Urol Int. 2023;107:839-840.
    >> Share

  32. SHEN C, Zhang DL, Cheng XL, Zhang WC, et al
    Urological Tumor: A Narrative Review of Tertiary Lymphatic Structures.
    Urol Int. 2023;107:841-847.
    >> Share

  33. YUAN P, Li X, Yuan Y, Xu P, et al
    Successful Kidney-Sparing Systemic Therapy for a High-Risk Ureteral Carcinoma Case.
    Urol Int. 2023;107:895-898.
    >> Share

  34. WANG C, Yu H, Fu W, Chen G, et al
    Transurethral Hem-o-lok Clip Ligation of the Distal Ureter in Retroperitoneal Laparoscopic Radical Nephroureterectomy.
    Urol Int. 2023;107.
    >> Share

  35. TULONE G, Pavan N, Giannone S, Abrate A, et al
    Double-Layered Hand-Sewn versus Stapled Intestinal Anastomosis in Patients Who Underwent Ileal Urinary Diversion in Radical Cystectomy: A Comparative and Cost Effective Study.
    Urol Int. 2023;107.
    >> Share

    June 2022
  36. PAREEK T, Parmar K, Sharma AP, Kumar S, et al
    Quality of Life, Efficacy, and Safety of Sequential Intravesical Gemcitabine + Docetaxel versus BCG for Non-Muscle Invasive Urinary Bladder Cancer: A Pilot Study.
    Urol Int. 2022 Jun 2:1-7. doi: 10.1159/000524098.
    >> Share

    February 2022
  37. KAMECKI H, Debowska M, Nyk L, Przewor A, et al
    The Clinical Features of Incidentally Diagnosed Urothelial Bladder Cancer: A Retrospective Data Analysis.
    Urol Int. 2022 Feb 11:1-8. doi: 10.1159/000521684.
    >> Share

  38. VOLZ Y, Pfitzinger PL, Eismann L, Ebner B, et al
    Prognostic Value of Pretreatment Inflammatory Markers in Patients Receiving Radical Cystectomy for Urothelial Bladder Cancer: Does Age Matter?
    Urol Int. 2022 Feb 8:1-8. doi: 10.1159/000521829.
    >> Share

  39. WEINHOLD P, Jokisch F, Schulz GB, Buchner A, et al
    Clinical Implication of Borderline CT-Morphological Metastatic Spread in Bladder Cancer: What You See Is Not Always What You Got.
    Urol Int. 2022 Feb 3:1-10. doi: 10.1159/000521857.
    >> Share

    January 2022
  40. LANNES F, Walz J, Maubon T, Rybikowski S, et al
    Enhanced Recovery after Surgery for Radical Cystectomy Decreases Postoperative Complications at Different Times.
    Urol Int. 2022;106:171-179.
    >> Share

  41. SHAO G, Xu C, Liu J, Li X, et al
    Clinical, Pathological, and Prognostic Analysis of Urachal Carcinoma.
    Urol Int. 2022;106:199-208.
    >> Share

  42. LIU Z, Zhang P, Wang H, Zheng B, et al
    Raman Spectrum-Based Diagnosis Strategy for Bladder Tumor.
    Urol Int. 2022;106:109-115.
    >> Share

  43. CHEN H, Wang M, Weng T, Wei Y, et al
    Prognostic Analysis of Diagnostic Ureteroscopic Biopsy for Intravesical Recurrence of Upper Urinary Tract Urothelial Carcinoma.
    Urol Int. 2022;106:186-194.
    >> Share

  44. ADAMCZYK P, Poblocki P, Kadlubowski M, Ostrowski A, et al
    Complication Rate after Radical Cystectomy Depends on the Surgical Technique and Patient's Clinical Status.
    Urol Int. 2022;106:163-170.
    >> Share

  45. LEE J, Suh J, Jeong CW, Kwak C, et al
    Efficacy of the Treatment of Intraperitoneal Bladder Perforation during Transurethral Resection of Bladder Tumor with the Urethral Catheter Alone: Retrospective Analysis of over 15 Years Using the Clinical Data Warehouse System.
    Urol Int. 2022;106:138-146.
    >> Share

  46. GROBET-JEANDIN E, Wirth GJ, Benamran D, Dupont A, et al
    Substaging of pT1 Urothelial Bladder Carcinoma Predicts Tumor Progression and Overall Survival.
    Urol Int. 2022;106:130-137.
    >> Share

  47. GRAFFEILLE V, Verhoest G, Gryn A, Kammerer-Jacquet SF, et al
    Complete Transurethral Resection before Radical Cystectomy May Improve Oncological Outcomes.
    Urol Int. 2022;106:122-129.
    >> Share

  48. STOKKEL LE, van de Kamp MW, Schaake EE, Boellaard TN, et al
    Robot-Assisted Partial Cystectomy versus Open Partial Cystectomy for Patients with Urachal Cancer.
    Urol Int. 2022;106:840-847.
    >> Share

  49. NIENTIEDT M, Waldbillig F, Stroop F, Nuhn P, et al
    Upper Tract Urinary Cancer Recurrence after Radical Cystectomy: Risk Assessment of Intraoperative Frozen Section.
    Urol Int. 2022;106:816-824.
    >> Share

  50. DREGER NM, Lohbeck A, Roth S, Godde D, et al
    Effectiveness and Safety of a Modified Technique of Transvesical Obturator Nerve Block to Avoid Adductor Contractions during Transurethral Resection of Bladder Tumors.
    Urol Int. 2022;106:775-783.
    >> Share

  51. SCHNEIDEWIND L, Torabi L, Drager DL, Hakenberg OW, et al
    Reduction of Perioperative Antibiotic Prophylaxis in Open Radical Cystectomy with Ileal Conduit Is Feasible: Results of a Prospective Clinical Trial.
    Urol Int. 2022;106:825-831.
    >> Share

  52. CILESIZ NC, Ozkan A, Kalkanli A, Gezmis CT, et al
    Spinal Anesthesia Provides Longer Administration Time for Postoperative Intravesical Chemotherapy after TUR-B Operation.
    Urol Int. 2022;106:768-774.
    >> Share

    December 2021
  53. ZAZZARA M, Nazaraj A, Scarcia M, Cardo G, et al
    Electromotive Drug Administration of Mitomycin C (EMDA/MMC) versus Intravesical Immunotherapy with Bacillus Calmette-Guerin (BCG) in Intermediate and High Risk Non Muscle Invasive Bladder Cancer.
    Urol Int. 2021 Dec 21:1-8. doi: 10.1159/000520630.
    >> Share

    November 2021
  54. PULLEN L, Kaspar C, Panic A, Hess J, et al
    Retrograde Pyelography in the Presence of Urothelial Bladder Cancer Does Not Affect the Risk of Upper Tract Urothelial Cancer: A Retrospective Analysis of a Single-Centre Cohort.
    Urol Int. 2021 Nov 10:1-6. doi: 10.1159/000519898.
    >> Share

    October 2021
  55. WANG Y, Qu H, Xu B, Wu J, et al
    Expression of FOXA1 Is Associated with the Tumor-Infiltrating M2 Macrophage, Cytotoxic T Lymphocyte, and Effect of Chemotherapy in Bladder Cancer.
    Urol Int. 2021 Oct 27:1-6. doi: 10.1159/000519129.
    >> Share

  56. SU Q, Gao S, Lu C, Wu X, et al
    Comparing Prognosis Associated with Partial Cystectomy and Trimodal Therapy for Muscle-Invasive Bladder Cancer Patients.
    Urol Int. 2021 Oct 14:1-12. doi: 10.1159/000518562.
    >> Share

    August 2021
  57. STRUCK JP, Hennig MJP, Hupe MC, Moharam N, et al
    Discrepancy between German S3 Guideline Recommendations and Daily Urologic Practice in the Management of Nonmuscle Invasive Bladder Cancer: Results of a Binational Survey.
    Urol Int. 2021 Aug 31:1-11. doi: 10.1159/000518166.
    >> Share

  58. RUCKHER J, Lobitz J, Follmann M, Derenz S, et al
    Guideline-Based Quality Indicators for Kidney and Bladder Cancer in Germany: Development and Implementation.
    Urol Int. 2021 Aug 12:1-8. doi: 10.1159/000517893.
    >> Share

  59. TOHI Y, Miyauchi Y, Yamasaki M, Fujiwara K, et al
    Incidental Bladder Cancer Found on Cystoscopy during Prostate Biopsy: Prevalence, Pathological Findings, and Oncological Outcome.
    Urol Int. 2021 Aug 5:1-7. doi: 10.1159/000517895.
    >> Share

  60. RAVENTOS BUSQUETS CX, Semidey ME, Lozano Palacio F, Carrion Puig A, et al
    Is Tumor Budding a New Predictor for Early Cystectomy in pT1 High-Grade Bladder Cancer?
    Urol Int. 2021 Aug 5:1-9. doi: 10.1159/000517543.
    >> Share

    June 2021
  61. GAO T, Ji Y
    Long Noncoding RNA LINC00707 Accelerates Tumorigenesis and Progression of Bladder Cancer via Targeting miR-145/CDCA3 Regulatory Loop.
    Urol Int. 2021 Jun 30:1-15. doi: 10.1159/000514388.
    >> Share

    March 2021
  62. CHEN P, Chen J, He L, Du C, et al
    Identification of circRNA-miRNA-mRNA Regulatory Network in Bladder Cancer by Integrated Analysis.
    Urol Int. 2021 Mar 31:1-11. doi: 10.1159/000512066.
    >> Share

  63. LIU Y, Huang X, Guo L, Luo N, et al
    LINC00649 Facilitates the Cellular Process of Bladder Cancer Cells via Signaling Axis miR-16-5p/JARID2.
    Urol Int. 2021 Mar 31:1-9. doi: 10.1159/000506239.
    >> Share

  64. LIU Z, Zhang Y, Sun G, Ouyang W, et al
    Comparison of Thulium Laser Resection of Bladder Tumors and Conventional Transurethral Resection of Bladder Tumors for Non-Muscle-Invasive Bladder Cancer.
    Urol Int. 2021 Mar 30:1-6. doi: 10.1159/000514042.
    >> Share

    February 2021
  65. YANG X, Zhuang J, Yu H, Cao Q, et al
    Effect of Coronavirus Disease 2019 on Patients with Bladder Cancer in China.
    Urol Int. 2021 Feb 24:1-3. doi: 10.1159/000512895.
    >> Share

    January 2021
  66. KAYNAR M, Celik ZE, Altintas E, Batur AF, et al
    Comparison of Two Different Bipolar Energy Resources in Transurethral Resection of Bladder Tumors.
    Urol Int. 2021;105.
    >> Share

  67. IZOL V, Deger M, Ozden E, Bolat D, et al
    The Effect of Diagnostic Ureterorenoscopy on Intravesical Recurrence in Patients Undergoing Nephroureterectomy for Primary Upper Tract Urinary Carcinoma.
    Urol Int. 2021;105.
    >> Share

  68. YANG C, Lv Z, Li Y
    Reduction of Bladder Volume after BCG Immunotherapy.
    Urol Int. 2021;105.
    >> Share

    December 2020
  69. RABER M, Buchholz N, Vercesi A, Hendawi NA, et al
    Treatment of Large Non-Muscle-Invasive Bladder Cancer: The Potential Role of Neoadjuvant Intravesical Chemotherapy.
    Urol Int. 2020 Dec 17:1-6. doi: 10.1159/000512052.
    >> Share

    January 2020
  70. SUZUKI K, Hinata N, Inoue TA, Nakamura I, et al
    Comparison of the Perioperative and Postoperative Outcomes of Ileal Conduit and Cutaneous Ureterostomy: A Propensity Score-Matched Analysis.
    Urol Int. 2020;104.
    >> Share

  71. POLETAJEW S, Krajewski W, Adamowicz J, Kolodziej A, et al
    Management of Intradiverticular Bladder Tumours: A Systematic Review.
    Urol Int. 2020;104.
    >> Share

  72. JOKISCH JF, Grimm T, Buchner A, Kretschmer A, et al
    Preoperative Thrombocytosis in Patients Undergoing Radical Cystectomy for Urothelial Cancer of the Bladder: An Independent Prognostic Parameter for an Impaired Oncological Outcome.
    Urol Int. 2020;104.
    >> Share

  73. ZHU C, Deng Z, Yuan L, Su J, et al
    Transurethral-Assisted Transumbilical Laparoendoscopic Single-Site Radical Cystectomy: Initial Short-Term Experience.
    Urol Int. 2020;104.
    >> Share

  74. SARIER M, Sepin N, Keles Y, Imir L, et al
    Is There any Association between Urothelial Carcinoma of the Bladder and Human Papillomavirus? A Case-Control Study.
    Urol Int. 2020;104.
    >> Share

  75. FROEHNER M, Koch R, Heberling U, Borkowetz A, et al
    Validation of a Questionnaire-Suitable Comorbidity Index in Patients Undergoing Radical Cystectomy.
    Urol Int. 2020;104.
    >> Share

  76. FEDELI U, De Paoli A, Corti MC, Cacciamani GE, et al
    Perioperative Mortality and Long-Term Survival after Radical Cystectomy: A Population-Based Study in a Southern European Country on 4,389 Patients.
    Urol Int. 2020;104.
    >> Share

  77. TAMALUNAS A, Buchner A, Kretschmer A, Jokisch F, et al
    Impact of Routine Laboratory Parameters in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Long-Term Follow-Up.
    Urol Int. 2020;104.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016